The impact of dental treatment and age on salivary cortisol and alpha-amylase levels of patients with varying degrees of dental anxiety

Majed AlMaummar, Huda Othman AlThabit, Sharat Pani, Majed AlMaummar, Huda Othman AlThabit, Sharat Pani

Abstract

Background: The purpose of this study was to assess the salivary cortisol and salivary alpha-amylase levels in children aged between 6 and 9 years, 3 months and 1 year after the successful completion of dental treatment through either pharmacological or non-pharmacological behavior management techniques.

Methods: A total of 1567 patients aged between 6 and 9 years who had completed dental treatment were screened. A total of 703 patients who were caries free at the end of 3 months were classified based on Frankl behavior score and administered the Arabic version of the Children's Fear Survey Schedule- Dental Subscale (CFSS-DS) and accordingly allocated to one of three groups; (Phobic Patients, Anxious Patients, Control Group). A total of 183 patients met the inclusion criteria and were followed up for 1 year. A total of 151 patients completed the study. Patients' heart rate on recall, salivary cortisol and salivary amylase were compared between the groups.

Results: The results of the study showed that amylase and cortisol levels had a significant association with the level of dental fear. The phobic patients had the highest levels of salivary amylase and salivary cortisol levels with no significant associations observed with either heart rate or extent of dental treatment. Control and anxious patients had significantly lower amylase levels when compared to phobic patients. There was no significant difference between the salivary cortisol levels of anxious and phobic patients. These findings were replicated on 1-year recall.

Conclusions: Within the limitations of this study we can conclude that salivary amylase is an indicator of of acute stress that can differentiate between anxiety and dental fear; while salivary cortisol appears to be a marker of long-term stress that lacks the sensitivity to differentiate between the two.

Keywords: Alpha-amylase; Anxiety; Cortisol; Dental fear; Salivary biomarkers.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Selection and Distribution of the study population

References

    1. Schuller AA, Willumsen T, Holst D. Are there differences in oral health and oral health behavior between individuals with high and low dental fear? Community Dent Oral Epidemiol. 2003;31(2):116–121. doi: 10.1034/j.1600-0528.2003.00026.x.
    1. Armfield JM, Slade GD, Spencer AJ. Dental fear and adult oral health in Australia. Community Dent Oral Epidemiol. 2009;37(3):220–230. doi: 10.1111/j.1600-0528.2009.00468.x.
    1. Armfield JM, Stewart JF, Spencer AJ. The vicious cycle of dental fear: exploring the interplay between oral health, service utilization and dental fear. BMC Oral Health. 2007;7:1. doi: 10.1186/1472-6831-7-1.
    1. APA . Diagnostic and statistical manual of mental disorders DSM-V. 5. Arlington: American Psychiatric Publishing; 2013.
    1. Oosterink FM, de Jongh A, Hoogstraten J. Prevalence of dental fear and phobia relative to other fear and phobia subtypes. Eur J Oral Sci. 2009;117(2):135–143. doi: 10.1111/j.1600-0722.2008.00602.x.
    1. de Jongh A, Muris P, ter Horst G, Duyx MP. Acquisition and maintenance of dental anxiety: the role of conditioning experiences and cognitive factors. Behav Res Ther. 1995;33(2):205–210. doi: 10.1016/0005-7967(94)P4442-W.
    1. Krikken JB, de Jongh A, Veerkamp JS, Vogels W, Cate JM, van Wijk AJ. Longitudinal changes in dental fear and coping behavior in children, adolescents, and young adults with cleft lip and/or cleft palate. Cleft Palate Craniofac J. 2015;52(4):e73–e80. doi: 10.1597/12-262.
    1. Poulton R, Waldie KE, Thomson WM, Locker D. Determinants of early- vs late-onset dental fear in a longitudinal-epidemiological study. Behav Res Ther. 2001;39(7):777–785. doi: 10.1016/S0005-7967(00)00060-7.
    1. Carlsson SG, Wide Boman U, Lundgren J, Hakeberg M. Dental anxiety - a joint interest for dentists and psychologists. Eur J Oral Sci. 2013;121(3 Pt 2):221–224. doi: 10.1111/eos.12046.
    1. Hagglin C, Carlsson SG, Hakeberg M. On the dynamics of dental fear: dental or mental? Eur J Oral Sci. 2013;121(3 Pt 2):235–239. doi: 10.1111/eos.12038.
    1. Coric A, Banozic A, Klaric M, Vukojevic K, Puljak L. Dental fear and anxiety in older children: an association with parental dental anxiety and effective pain coping strategies. J Pain Res. 2014;7:515–521.
    1. Corkey B, Freeman R. Predictors of dental anxiety in six-year-old children: findings from a pilot study. ASDC J Dent Child. 1994;61(4):267–271.
    1. Jessop DS, Turner-Cobb JM. Measurement and meaning of salivary cortisol: a focus on health and disease in children. Stress (Amsterdam, Netherlands) 2008;11(1):1–14. doi: 10.1080/10253890701365527.
    1. Hellhammer DH, Wust S, Kudielka BM. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology. 2009;34(2):163–171. doi: 10.1016/j.psyneuen.2008.10.026.
    1. Blomqvist M, Holmberg K, Lindblad F, Fernell E, Ek U, Dahllof G. Salivary cortisol levels and dental anxiety in children with attention deficit hyperactivity disorder. Eur J Oral Sci. 2007;115(1):1–6. doi: 10.1111/j.1600-0722.2007.00423.x.
    1. Kanegane K, Penha SS, Munhoz CD, Rocha RG. Dental anxiety and salivary cortisol levels before urgent dental care. J Oral Sci. 2009;51(4):515–520. doi: 10.2334/josnusd.51.515.
    1. Nater UM, La Marca R, Florin L, Moses A, Langhans W, Koller MM, et al. Stress-induced changes in human salivary alpha-amylase activity -- associations with adrenergic activity. Psychoneuroendocrinology. 2006;31(1):49–58. doi: 10.1016/j.psyneuen.2005.05.010.
    1. Nater UM, Rohleder N, Gaab J, Berger S, Jud A, Kirschbaum C, et al. Human salivary alpha-amylase reactivity in a psychosocial stress paradigm. Int J Psychophysiol. 2005;55(3):333–342. doi: 10.1016/j.ijpsycho.2004.09.009.
    1. Rashkova MR, Ribagin LS, Toneva NG. Correlation between salivary alpha-amylase and stress-related anxiety. Folia Med. 2012;54(2):46–51. doi: 10.2478/v10153-011-0088-4.
    1. Pani S. C., Al Odhaib M. The impact of dental treatment on the salivary cortisol levels of children with severe early childhood caries. European Archives of Paediatric Dentistry. 2013;14(5):307–312. doi: 10.1007/s40368-013-0083-y.
    1. Pani SC, AlGarni B, AlZain LM, AlQahtani NS. Assessment of the impact of stress and anxiety on pain perception in patients undergoing surgery for placement of their first dental implant. Oral Health Dent Manage. 2014;13(2):464–468.
    1. Wannemueller A, Adolph D, Joehren HP, Blackwell SE, Margraf J. Psychophysiological reactivity of currently dental phobic-, remitted dental phobic- and never-dental phobic individuals during exposure to dental-related and other affect-inducing materials. Behav Res Ther. 2017;90:76–86. doi: 10.1016/j.brat.2016.12.009.
    1. Putnam Susan K., Lopata Christopher, Fox Jeffery D., Thomeer Marcus L., Rodgers Jonathan D., Volker Martin A., Lee Gloria K., Neilans Erik G., Werth Jilynn. Comparison of Saliva Collection Methods in Children with High-Functioning Autism Spectrum Disorders: Acceptability and Recovery of Cortisol. Child Psychiatry & Human Development. 2012;43(4):560–573. doi: 10.1007/s10578-012-0284-3.
    1. El-Housseiny AA, Alamoudi NM, Farsi NM, El Derwi DA. Characteristics of dental fear among Arabic-speaking children: a descriptive study. BMC Oral Health. 2014;14:118. doi: 10.1186/1472-6831-14-118.
    1. El-Housseiny AA, Merdad LA, Alamoudi NM, Farsi NM. Effect of child and parent characteristics on child dental fear ratings: analysis of short and full versions of the children’s fear survey schedule-dental subscale. Oral Health Dent Manage. 2015;14:245–46.
    1. ten Berge M, Hoogstraten J, Veerkamp JS, Prins PJ. The dental subscale of the Children's fear survey schedule: a factor analytic study in the Netherlands. Community Dent Oral Epidemiol. 1998;26(5):340–343. doi: 10.1111/j.1600-0528.1998.tb01970.x.
    1. ten Berge M, Veerkamp JS, Hoogstraten J, Prins PJ. Childhood dental fear in the Netherlands: prevalence and normative data. Community Dent Oral Epidemiol. 2002;30(2):101–107. doi: 10.1034/j.1600-0528.2002.300203.x.
    1. Blomqvist M, Ek U, Fernell E, Holmberg K, Westerlund J, Dahllof G. Cognitive ability and dental fear and anxiety. Eur J Oral Sci. 2013;121(2):117–120. doi: 10.1111/eos.12028.
    1. Arapostathis KN, Coolidge T, Emmanouil D, Kotsanos N. Reliability and validity of the Greek version of the Children's fear survey schedule-dental subscale. Int J Paediatric Dent Br Paedodontic Soc Int Assoc Dent Children. 2008;18(5):374–379.
    1. Nakai Y, Hirakawa T, Milgrom P, Coolidge T, Heima M, Mori Y, et al. The Children's fear survey schedule-dental subscale in Japan. Community Dent Oral Epidemiol. 2005;33(3):196–204. doi: 10.1111/j.1600-0528.2005.00211.x.
    1. Beck FM, Weaver JM., 2nd Blood pressure and heart rate responses to anticipated high-stress dental treatment. J Dent Res. 1981;60(1):26–29. doi: 10.1177/00220345810600010501.
    1. Myers DR, Kramer WS, Sullivan RE. A study of the heart action of the child dental patient. ASDC J Dent Child. 1972;39(2):99–106.
    1. Guinot Jimeno F, Yuste Bielsa S, Cuadros Fernandez C, Lorente Rodriguez AI, Mercade Bellido M. Objective and subjective measures for assessing anxiety in paediatric dental patients. Eur J Paediatr Dent. 2011;12(4):239–244.
    1. Furlan NF, Gaviao MB, Barbosa TS, Nicolau J, Castelo PM. Salivary cortisol, alpha-amylase and heart rate variation in response to dental treatment in children. J Clin Pediatr Dent. 2012;37(1):83–87. doi: 10.17796/jcpd.37.1.n32m21n08417v363.
    1. Nater U, Rohleder N. Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research. Psychoneuroendocrinology. 2009;34(4):486–496. doi: 10.1016/j.psyneuen.2009.01.014.
    1. Shah B, Ashok L, Sujatha G. Evaluation of salivary cortisol and psychological factors in patients with oral lichen planus. Indian J Dent Res. 2009;20(3):288. doi: 10.4103/0970-9290.57361.
    1. Miller CS, Dembo JB, Falace DA, Kaplan AL. Salivary cortisol response to dental treatment of varying stress. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79(4):436–441. doi: 10.1016/S1079-2104(05)80123-4.
    1. Benjamins C, Asscheman H, Schuurs AH. Increased salivary cortisol in severe dental anxiety. Psychophysiology. 1992;29(3):302–305. doi: 10.1111/j.1469-8986.1992.tb01703.x.
    1. Sadi H, Finkelman M, Rosenberg M. Salivary cortisol, salivary alpha amylase, and the dental anxiety scale. Anesth Prog. 2013;60(2):46–53. doi: 10.2344/0003-3006-60.2.46.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit